 | • レポートコード：PMR-20JN003 • 出版社/出版日：Persistence Market Research / 2020年1月20日 • レポート形態：英文、PDF、182ページ • 納品方法：Eメール • 産業分類：ライフサイエンス＆革新医療 |
| Individual User（1名用） | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User（5名用） | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Corporate User（企業用） | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートでは、神経障害性疼痛管理の世界市場を調査・分析することにより、今後の方向性を明らかに提示しております。市場動向、市場力学、キーインクルージョン、価値分析、薬物クラス別（三環系抗うつ薬、抗痙攣薬、SNRI、カプサイシンクリーム、局所麻酔、オピオイド、ステロイド、その他）分析、疾患別（糖尿病性神経障害、三叉神経痛、帯状疱疹後神経痛、化学療法誘発性末梢神経障害、その他）分析、流通チャンネル別（小売薬局、病院薬局、オンライン薬局）分析、地域別分析、競合分析などを整理しております。 ・エグゼクティブサマリー ・市場動向 ・市場力学 ・キーインクルージョン ・価値分析 ・神経障害性疼痛管理の世界市場：薬物クラス別（三環系抗うつ薬、抗痙攣薬、SNRI、カプサイシンクリーム、局所麻酔、オピオイド、ステロイド、その他） ・神経障害性疼痛管理の世界市場：疾患別（糖尿病性神経障害、三叉神経痛、帯状疱疹後神経痛、化学療法誘発性末梢神経障害、その他） ・神経障害性疼痛管理の世界市場：流通チャンネル別（小売薬局、病院薬局、オンライン薬局） ・神経障害性疼痛管理の世界市場：地域別 ・競合分析 |
Neuropathic Pain Management Market – Scope of the Report
Persistence Market Research (PMR) recently published a market study on the global market for neuropathic pain management. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the neuropathic pain management market structure. The market study presents exclusive information about how the neuropathic pain management market will grow during the forecast period of 2019-2029.
Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the neuropathic pain management market during the forecast period.
The study is relevant for stakeholders in the neuropathic pain management market, including neuropathic pain management therapy manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the neuropathic pain management market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in PMR’s study.
The study also includes statistics as well as facts related to macro as well as microeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the neuropathic pain management market. Furthermore, small businesses and new entrants in the neuropathic pain management market too can make use of the information presented in this study, based on which, they can make appropriate business decisions to gain momentum in the market.
Key Questions Answered in PMR’s Neuropathic Pain Management Market Report
Which regions will continue to remain the most profitable regional markets for neuropathic pain management market players?
Which factors will induce a change in the demand for neuropathic pain management therapy during the assessment period?
How will changing trends impact the neuropathic pain management market?
How can market players capture the low-hanging opportunities in the neuropathic pain management market in developed regions?
Which companies are leading the neuropathic pain management market?
What are the winning strategies of stakeholders in the neuropathic pain management market to upscale their position in this landscape?
Neuropathic Pain Management Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the neuropathic pain management market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.
Secondary resources referred to analysts during the production of the neuropathic pain management market study include statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the neuropathic pain management market, and makes PMR’s projection on the growth prospects of the neuropathic pain management market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Dynamics
3.1. Macro-Economic Factors
3.2. Drivers
3.2.1. Supply Side Drivers
3.2.2. Demand Side Drivers
3.3. Restraints
3.4. Opportunities
3.5. Trends
4. Key Inclusions
4.1. Clinical Trials
5. Global Neuropathic Pain Management Market Value Analysis 2014-2018 and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Class
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2014-2018
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2019 – 2029
6.3.1. Tricyclic Anti-Depressants
6.3.2. Anticonvulsants
6.3.3. SNRI’s
6.3.4. Capsaicin Cream
6.3.5. Local Anaesthesia
6.3.6. Opioids
6.3.7. Steroids
6.3.8. Others
6.4. Market Attractiveness Analysis By Drug Class
7. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Indication
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014-2018
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019 – 2029
7.3.1. Diabetic Neuropathy
7.3.2. Trigeminal Neuralgia
7.3.3. Post-Herpetic Neuralgia
7.3.4. Chemotherapy-Induced Peripheral Neuropathy
7.3.5. Others
7.4. Market Attractiveness Analysis By Indication
8. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029
8.3.1. Retail Pharmacies
8.3.2. Hospital Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness Analysis By Distribution Channel
9. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Region
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018
9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Drug Class
10.3.3. By Indication
10.3.4. By Distribution Channel
10.4. Market Attractiveness Analysis
10.5. Key Impact Analysis
11. Latin America Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Argentina
11.3.1.4. Rest of Latin America
11.3.2. By Drug Class
11.3.3. By Indication
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.5. Key Impact Analysis
12. Europe Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
12.3.1. By Country
12.3.1.1. U.K.
12.3.1.2. Germany
12.3.1.3. France
12.3.1.4. Italy
12.3.1.5. Spain
12.3.1.6. Russia
12.3.1.7. Rest of Europe
12.3.2. By Drug Class
12.3.3. By Indication
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.5. Key Impact Analysis
13. Asia Pacific Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
13.3.1. By Country
13.3.1.1. China
13.3.1.2. India
13.3.1.3. Australia and NZ
13.3.1.4. ASEAN
13.3.1.5. Rest of Asia Pacific
13.3.2. By Drug Class
13.3.3. By Indication
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.5. Key Impact Analysis
14. Middle East and Africa Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
14.3.1. By Country
14.3.1.1. GCC Countries
14.3.1.2. South Africa
14.3.1.3. Rest of MEA
14.3.2. By Drug Class
14.3.3. By Indication
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.5. Key Impact Analysis
15. Competition Analysis
15.1. Competition Dashboard
15.2. Competition Deep Dive
15.2.1. Pfizer Inc.
15.2.1.1. Company Overview
15.2.1.2. Segment Overview
15.2.1.3. ProductOfferings
15.2.1.4. Financial Analysis
15.2.1.5. Key Developments
15.2.1.6. Strategy Overview
15.2.2. Johnson & Johnson Services, Inc.
15.2.2.1. Company Overview
15.2.2.2. Segment Overview
15.2.2.3. ProductOfferings
15.2.2.4. Financial Analysis
15.2.2.5. Key Developments
15.2.2.6. Strategy Overview
15.2.3. Bristol-Myers Squibb Company
15.2.3.1. Company Overview
15.2.3.2. Segment Overview
15.2.3.3. ProductOfferings
15.2.3.4. Financial Analysis
15.2.3.5. Key Developments
15.2.3.6. Strategy Overview
15.2.4. Sanofi S.A
15.2.4.1. Company Overview
15.2.4.2. Segment Overview
15.2.4.3. ProductOfferings
15.2.4.4. Financial Analysis
15.2.4.5. Key Developments
15.2.4.6. Strategy Overview
15.2.5. GlaxoSmithKline plc
15.2.5.1. Company Overview
15.2.5.2. Segment Overview
15.2.5.3. ProductOfferings
15.2.5.4. Financial Analysis
15.2.5.5. Key Developments
15.2.5.6. Strategy Overview
15.2.6. Eli Lilly and Company
15.2.6.1. Company Overview
15.2.6.2. Segment Overview
15.2.6.3. ProductOfferings
15.2.6.4. Financial Analysis
15.2.6.5. Key Developments
15.2.6.6. Strategy Overview
15.2.7. Teva Pharmaceutical Industries Ltd
15.2.7.1. Company Overview
15.2.7.2. Segment Overview
15.2.7.3. ProductOfferings
15.2.7.4. Financial Analysis
15.2.7.5. Key Developments
15.2.7.6. Strategy Overview
15.2.8. Baxter International Inc
15.2.8.1. Company Overview
15.2.8.2. Segment Overview
15.2.8.3. ProductOfferings
15.2.8.4. Financial Analysis
15.2.8.5. Key Developments
15.2.8.6. Strategy Overview
16. Assumptions and Acronyms Used
17. Research Methodology
List of TablesTable 01: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 02: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 03: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 04: Global Neuropathic Pain Management Size (US$ Mn) 2014-2018 and Forecast 2019-2029 By Region,
Table 05: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 06: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 07: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 08: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 09: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 10: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 11: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 12: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 13: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 14: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 15: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 16: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 17: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 18: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 19: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 20: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 21: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 22: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 23: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 24: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel